2023
Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
Fitzpatrick M, Moghadas S, Vilches T, Shah A, Pandey A, Galvani A. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination. JAMA Network Open 2023, 6: e2313586. PMID: 37204795, PMCID: PMC10199352, DOI: 10.1001/jamanetworkopen.2023.13586.Peer-Reviewed Original ResearchMeSH KeywordsAbsenteeismChildCOVID-19Health PromotionHospitalizationHumansInfluenza, HumanSchoolsVaccinationConceptsBooster campaignBooster vaccinationInfluenza vaccinationPediatric populationDecision analytical modelSchool absenteeismIntensive carePediatric hospitalizationsEligible individualsMAIN OUTCOMEAge groupsIntensive care unit admissionCare unit admissionSeasonal influenza vaccinationCOVID-19 illnessCOVID-19 prevention strategiesEligible age groupDecreased hospitalizationsUnit admissionCOVID-19 transmissionSymptomatic infectionAdverse outcomesIsolation daysHospitalizationGeneral populationExacerbation of measles mortality by vaccine hesitancy worldwide
Pandey A, Galvani A. Exacerbation of measles mortality by vaccine hesitancy worldwide. The Lancet Global Health 2023, 11: e478-e479. PMID: 36925157, DOI: 10.1016/s2214-109x(23)00063-3.Peer-Reviewed Original Research
2022
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
Du Z, Wang L, Pandey A, Lim WW, Chinazzi M, Piontti APY, Lau EHY, Wu P, Malani A, Cobey S, Cowling BJ. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nature Medicine 2022, 28: 934-938. PMID: 35210596, PMCID: PMC9117137, DOI: 10.1038/s41591-022-01736-z.Peer-Reviewed Original ResearchConceptsLarge-scale survey dataEconomic benefitsFull dose vaccinationSurvey dataHospital admission costsDose-sparing strategiesCost of hospitalizationCOVID-19 deathsPopulation-level transmissionVaccine dosesVaccination strategiesAdmission costsEconomic burdenVaccine shortageFractional dosesVaccinationDose fractionationHigh transmissibilityVaccine distributionCostPublic healthVaccineWillingnessDosesIndia
2021
Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout
Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, Galvani AP. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. Journal Of Global Health 2021, 11: 03083. PMID: 34221355, PMCID: PMC8243816, DOI: 10.7189/jogh.11.03083.Peer-Reviewed Original Research
2019
The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo
Wells CR, Pandey A, Mbah M, Gaüzère BA, Malvy D, Singer BH, Galvani AP. The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 24366-24372. PMID: 31636188, PMCID: PMC6883813, DOI: 10.1073/pnas.1913980116.Peer-Reviewed Original ResearchConceptsCase isolationEbola treatment centersPopulation-level effectivenessPublic health responseHealthcare workersVaccination effortsTreatment centersHealth responseEbola transmissionInfectious diseasesEpidemic trajectoriesEbola outbreakDisease transmissionIncidenceEpidemicTemporal incidenceDemocratic RepublicExacerbationVaccinationDiseaseEbola vaccination in the Democratic Republic of the Congo
Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. Ebola vaccination in the Democratic Republic of the Congo. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 10178-10183. PMID: 31036657, PMCID: PMC6525480, DOI: 10.1073/pnas.1817329116.Peer-Reviewed Original ResearchMeSH KeywordsDemocratic Republic of the CongoEbola VaccinesHemorrhagic Fever, EbolaHumansTime FactorsVaccinationConceptsContacts of casesImpact of vaccinationFrontline healthcare workersEbola vaccinationEbola vaccineVaccination programHealthcare workersLong-range disseminationVaccination campaignCase confirmationEbola transmissionHigh-risk regionsEbola riskVaccinationFuture outbreaksRiskEarly implementationEbolaLevel of riskDemocratic RepublicGlobal spreadOutbreakVaccineInfectionDoses
2016
One Health approach to cost-effective rabies control in India
Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP. One Health approach to cost-effective rabies control in India. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016, 113: 14574-14581. PMID: 27994161, PMCID: PMC5187709, DOI: 10.1073/pnas.1604975113.Peer-Reviewed Original ResearchConceptsHuman rabiesRabies deathsCanine vaccinationStray dogsHuman rabies deathsRabies controlCost-effectiveness thresholdPostexposure vaccinationWHO criteriaDog bitesAutopsy dataHealth outcomesHealth approachSurveillance dataVaccinationCost-effective strategyDogsRabiesRabies surveillance dataOne-third